Concepedia

Manfred Kraus

MK

29

Publications

2.5K

Citations

22

H-Index

1957

Active since

Affiliations

Harvard University(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

University of Cologne

Pfizer (United States)

Dana-Farber/Boston Children's Cancer and Blood Disorders Center

Manfred Kraus is an author at Harvard University specializing in medicine, cell signaling, and cell biology.

ORCID

Top concepts

Publications per year

1957–2023

29

Publications

29

Survival of Resting Mature B Lymphocytes Depends on BCR Signaling via the Igα/β Heterodimer

Manfred Kraus, Marat Alimzhanov, Nikolaus Rajewsky et al. · Cell · 2004 · 567 citations · Full text

, , +7

Critical functions for c-Myb at three checkpoints during thymocyte development

Timothy P. Bender, Christopher S Kremer, Manfred Kraus et al. · Nature Immunology · 2004 · 186 citations

, , +10

Pathway-Based Identification of Biomarkers for Targeted Therapeutics: Personalized Oncology with PI3K Pathway Inhibitors

Jannik N. Andersen, Sriram Sathyanarayanan, Alessandra Di Bacco et al. · Science Translational Medicine · 2010 · 162 citations

Basal Immunoglobulin Signaling Actively Maintains Developmental Stage in Immature B Cells

Lina E. Tze, Brian R. Schram, Kong‐Peng Lam et al. · PLoS Biology · 2005 · 139 citations · Full text

, , +17

Discovery of a Novel and Selective Indoleamine 2,3-Dioxygenase (IDO-1) Inhibitor 3-(5-Fluoro-1<i>H</i>-indol-3-yl)pyrrolidine-2,5-dione (EOS200271/PF-06840003) and Its Characterization as a Potential Clinical Candidate

Stefano Crosignani, Patrick Bingham, Pauline Bottemanne et al. · Journal of Medicinal Chemistry · 2017 · 134 citations · Full text

Rows per page

1–5 of 29